About Jupiter Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
37
SWOG Cancer Research Network
5
Alliance for Clinical Trials in Oncology
4
Gynecologic Oncology Group
3
Exact Sciences Corporation
2
Abbott Medical Devices
1
Accuray Incorporated
1
B. Braun Medical Inc.
1
Barry Miskin, MD
1
Dartmouth-Hitchcock Medical Center
1
ECOG-ACRIN Cancer Research Group
1
Clinical Trials at Jupiter Medical Center
During the past decade, Jupiter Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 42 clinical trials were completed, i.e. on
average, 420% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 10 clinical trials were completed. i.e. 1000%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
2004-06-01
Unknown status
250
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
2004-06-15
2008-01-08
Completed
55
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
2005-06-01
2012-08-01
Completed
823
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
2005-08-15
2017-11-28
Completed
188
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
2005-05-01
2014-04-01
Completed
245
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jupiter Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 5 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Gynecologic Oncology Group" with 3 trials sponsored and "Exact Sciences Corporation"
with 3 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jupiter Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 21 trials.
Clinical Trials Conditions at Jupiter Medical Center
According to Clinical.Site data, the most researched conditions in "Jupiter Medical Center" are
"Recurrent Breast Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Jupiter Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Jupiter Medical Center
Most popular intervention types in "Jupiter Medical Center" are "Drug" (51 trials), "Other" (46 trials), "Biological" (25 trials), "Radiation" (9 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (15 trials), "Paclitaxel" (14 trials), "Bevacizumab" (11 trials) and "Carboplatin" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Jupiter Medical Center
The vast majority of trials in "Jupiter Medical Center" are
54 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Jupiter Medical Center
Currently, there are NaN active trials in "Jupiter Medical Center".
undefined are not yet recruiting,
1 are recruiting,
29 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 31 completed trials in Jupiter Medical Center,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Jupiter Medical Center, 3 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 40 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Jupiter Medical Center
Jupiter Medical Center has several departments that took part in Clinical trials: "Ella Milbank Foshay Cancer Center at Jupiter Medical Center" - 60 trials
Departments List
Name
City
Trials